Pseudomonas Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pseudomonas stocks.

Pseudomonas Stocks Recent News

Date Stock Title
May 31 NEPH GEE Group And 2 Other Stocks Under $3 Insiders Are Buying
May 30 INSM Insmed to Host Commercial Webinar on June 4, 2024
May 30 INSM Insmed announces pricing of $650M public offering
May 30 INSM Insmed Announces Pricing of $650 Million Public Offering of Common Stock
May 29 GLYC GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
May 29 INSM Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
May 29 INSM Insmed PT Raised to $67 at TD Cowen
May 29 INSM Insmed stocks soar as Phase III lung disease drug exceeds expectations
May 29 INSM Insmed intends to raise $500M via equity offering
May 28 INSM Insmed Announces Proposed $500 Million Public Offering of Common Stock
May 28 INSM Insmed stock blasts off over lung condition study results
May 28 INSM Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)
May 28 INSM The Next Humira? Insmed Catapults 113% On Its 'Very Attractive' Opportunity In Lung Disease.
May 28 INSM Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
May 28 INSM Stocks to Watch Tuesday: GameStop, Apple, Nvidia, Hess
May 28 INSM Insmed Shares Rocket After Drug Eases Lung Disease Symptoms
May 28 INSM Insmed Stock More Than Doubles on Trial Win for Lung-Condition Drug
May 28 INSM Insmed shares double as lung drug data convince Wall Street
May 28 INSM Insmed surges on late-stage win for lung disease therapy
May 28 INSM Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
Pseudomonas

Pseudomonas is a genus of Gram-negative, Gammaproteobacteria, belonging to the family Pseudomonadaceae and containing 191 validly described species. The members of the genus demonstrate a great deal of metabolic diversity and consequently are able to colonize a wide range of niches. Their ease of culture in vitro and availability of an increasing number of Pseudomonas strain genome sequences has made the genus an excellent focus for scientific research; the best studied species include P. aeruginosa in its role as an opportunistic human pathogen, the plant pathogen P. syringae, the soil bacterium P. putida, and the plant growth-promoting P. fluorescens.
Because of their widespread occurrence in water and plant seeds such as dicots, the pseudomonads were observed early in the history of microbiology. The generic name Pseudomonas created for these organisms was defined in rather vague terms by Walter Migula in 1894 and 1900 as a genus of Gram-negative, rod-shaped and polar-flagellated bacteria with some sporulating species, the latter statement was later proved incorrect and was due to refractive granules of reserve materials. Despite the vague description, the type species, Pseudomonas pyocyanea (basonym of Pseudomonas aeruginosa), proved the best descriptor.

Browse All Tags